Iovance Biotherapeutics
Price & Volume
Stats
See moreOpen | $5.93 |
Previous Close | $5.88 |
Day Range | $5.90-$6.03 |
52W Range | $5.57-$18.33 |
Market Cap | $1.8B |
Shares Short | 61M |
Financials
See moreRevenue (12 Mos) | $90.8M |
Revenue Growth (YoY) | 12,385.1% |
Gross Profit (12 Mos) | $8M |
Diluted EPS | -$1.48 |
News
See moreYahoo Finance • 2 days ago
Is Iovance Biotherapeutics (IOVA) Among Billionaire Joseph Edelman’s Long-Term Stock Picks?
Yahoo Finance • 5 days ago
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Yahoo Finance • 5 months ago
3 Monster Biotech Stocks to Buy Before 2025
Yahoo Finance • 8 months ago
Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual Meeting
About
CEO | Dr. Frederick G. Vogt Esq., J.D., Ph.D. |
CFO | Mr. Jean-Marc Bellemin M.B.A. |
Address | 825 Industrial Road, San Carlos, CA, United States, 94070 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 557 |
